Needham & Company analyst Mike Matson reiterated a Strong Buy and $43 price target on Boston Scientific (NYSE: BSX) as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE